Mariner’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-47,691
Closed -$713K 2937
2022
Q4
$713K Buy
+47,691
New +$660K ﹤0.01% 1421

Mariner's AVEO Position: Q1 2023 in Review

Mariner sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 47,691 shares — an estimated $713K sold.

Mariner first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $713K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Mariner reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Mariner sold 47,691 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $713K.
  • Mariner first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Mariner's AVEO Pharmaceuticals, Inc. position peaked at $713K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Mariner's 13F filing for Q1 2023, filed 15 May 2023.